SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Geriatric Psychiatry and Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sommer, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sommer, B. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Parkinson's Disease
*Patient Rights
*Psychotic Disorders
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Quetiapine-Induced Extrapyramidal Side Effects in Patients with Parkinson's Disease: Case Report

Barbara R. Sommer, MD

Although quetiapine is the antipsychotic of choice for the psychosis associated with Parkinson's disease (PD) and often is also helpful for sleep, we report two cases of quetiapine-induced extrapyramidal side effects. The patients described were unusual in their frailty and severity of illness and may not represent the majority of patients with PD. (J Geriatr Psychiatry Neurol 2001; 14:99-100).

Journal of Geriatric Psychiatry and Neurology, Vol. 14, No. 2, 99-100 (2001)
DOI: 10.1177/089198870101400210
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 AM J ALZHEIMERS DIS OTHER DEMENHome page
M. L. Onor, M. Saina, and E. Aguglia
Efficacy and Tolerability of Quetiapine in the Treatment of Behavioral and Psychological Symptoms of Dementia
American Journal of Alzheimer's Disease and Other Dementias, January 1, 2007; 21(6): 448 - 453.
[Abstract] [PDF]

Home page
 Arch Intern MedHome page
S. Gill, C. Marras, G. M. Anderson, P. E. Lee, J. H. Gurwitz, and P. A. Rochon
Atypical Antipsychotics Have Very Different Adverse Effect Profiles and Should Not Be Lumped Together--Reply
Arch Intern Med, March 13, 2006; 166(5): 586 - 587.
[Full Text] [PDF]

Home page
 PsychosomaticsHome page
G. Catalano, J. W. Grace, M. C. Catalano, M. J. Morales, and L. M. Cruse
Acute Akathisia Associated With Quetiapine Use
Psychosomatics, August 1, 2005; 46(4): 291 - 301.
[Abstract] [Full Text] [PDF]

Home page
 J. Neuropsychiatry Clin. Neurosi.Home page
M. S. Ismail and I. H. Richard
A Reality Test: How Well Do We Understand Psychosis in Parkinson's Disease?
J Neuropsychiatry Clin Neurosci, February 1, 2004; 16(1): 8 - 18.
[Abstract] [Full Text] [PDF]


Advertisement